seroxat 20 mg film - coated tablets
smithkline beecham ltd., - Пароксетин - 20 mg film - coated tablets
duosol without potassium 2 mmol/1 potassium solution for haemofiltration
2 mmol/1 potassium solution for haemofiltration
duosol without potassium 4 mmol/1 potassium solution for haemofiltration
4 mmol/1 potassium solution for haemofiltration
duosol without potassium solution for haemofiltration
solution for haemofiltration
dupixent
sanofi winthrop industrie - dupilumab - dermatitis, atopic; prurigo; esophageal diseases; asthma; sinusitis - Средства за дерматит, с изключение на кортикостероиди - atopic dermatitisadults and adolescentsdupixent is indicated for the treatment of moderate-to-severe atopic dermatitis in adults and adolescents 12 years and older who are candidates for systemic therapy. children 6 months to 11 years of agedupixent is indicated for the treatment of severe atopic dermatitis in children 6 months to 11 years old who are candidates for systemic therapy. asthmaadults and adolescentsdupixent is indicated in adults and adolescents 12 years and older as add-on maintenance treatment for severe asthma with type 2 inflammation characterised by raised blood eosinophils and/or raised fraction of exhaled nitric oxide (feno), see section 5. 1, who are inadequately controlled with high dose inhaled corticosteroids (ics) plus another medicinal product for maintenance treatment. children 6 to 11 years of agedupixent is indicated in children 6 to 11 years old as add-on maintenance treatment for severe asthma with type 2 inflammation characterised by raised blood eosinophils and/or raised fraction of exhaled nitric oxide (feno), who are inadequately controlled with medium to high dose inhaled corticosteroids (ics) plus another medicinal product for maintenance treatment. chronic rhinosinusitis with nasal polyposis (crswnp)dupixent is indicated as an add-on therapy with intranasal corticosteroids for the treatment of adults with severe crswnp for whom therapy with systemic corticosteroids and/or surgery do not provide adequate disease control. prurigo nodularis (pn)dupixent is indicated for the treatment of adults with moderate-to-severe prurigo nodularis (pn) who are candidates for systemic therapy. eosinophilic esophagitis (eoe)dupixent is indicated for the treatment of eosinophilic esophagitis in adults and adolescents 12 years and older, weighing at least 40 kg, who are inadequately controlled by, are intolerant to, or who are not candidates for conventional medicinal therapy.
panadol rapide 500 mg film - coated tablets
glaxosmithkline consumer healthcare, glaxosmithkline export ltd - Парацетамол - 500 mg film - coated tablets
coldrex nite 1000 mg/20 mg/15 mg/20 ml syrup
glaxosmithkline consumer healthcare, glaxosmithkline export ltd - 1000 mg/20 mg/15 mg/20 ml syrup
panadol soluble 500 mg soluble tablets
glaxosmithkline consumer healthcare, glaxosmithkline export ltd - Парацетамол - 500 mg soluble tablets
Зантак 75 mg филмирани таблетки x 6 x 12
glaxosmithkline consumer healthcare, glaxosmithkline export ltd - Ранитидин -
corsodyl mint 0,2 g/100 ml oromucosal solution
glaxosmithkline consumer healthcare, glaxosmithkline export ltd - Хлорхексидин - 0,2 g/100 ml oromucosal solution